Author

Adebimpe Adefolaju

University of North Carolina at Chapel HillORCID 0000-0002-6601-8305Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1 Organism:rat· 1

Frequent Co-Authors

Alain ValdiviaiD· 2 shared Andrew SatterleeiD· 2 shared Shawn HingtgeniD· 2 shared Aziz SancariD· 1 shared Breanna ManniD· 1 shared Caroline Mosely· 1 shared Catherine S. John· 1 shared Corey J. Haswell· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alain ValdiviaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedDec 31, 2025

Combinatorial Treatment of Glioblastoma with Temozolomide (TMZ) Plus 5-Ethynyl-2'-deoxyuridine (EdU)

Humeyra Kaanoglu, Yasemin Kübra Akyel, Adebimpe Adefolaju…·Aziz Sancar

This study evaluates the combination of TMZ and EdU in treating GBM, showing improved antitumor efficacy in vitro and in preclinical models.

6 citations

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 14, 2024

A Novel ex-vivo platform for personalized treatment in metastatic ovarian cancer.

Alain Valdivia, Adebimpe Adefolaju, Morrent Thang…·Shawn Hingtgen

This study develops an ex-vivo platform using rat mesenteric membranes to assess treatment response in ovarian cancer, showing correlation with clinical outcomes.

DOI 10.1101/2024.03.14.585117

𝕏 PostBluesky